lc28-0126
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2012 (NCT01737424)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lc28-0126
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03196804 | Phase 1 | Jun 7, 2017 | LG |
| NCT02770664 | Phase 2 | Apr 1, 2016 | LG |
| NCT02070471 | Phase 2 | Jan 1, 2014 | LG |
| NCT01737424 | Phase 1 | Dec 1, 2012 | LG, Seoul National University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LG | For profit | 4 | 4 | 2 | 2012 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1